× HOME INDUSTRIES INSIGHTS ABOUT CONTACT

North America Injectable Bone Graft Market Size and Share 2026 to 2033

North America Injectable Bone Graft Market Size, Share, Trends and Growth, by Segments Material Type, Application, End-User by 2026-2033

ID : MRU_431436 | Date : Oct 2026 | Pages : 253 | Region : North America | Base Year : 2025 | Forecast : 2026-2033

North America Injectable Bone Graft Market - Key Highlights

  • The North America Injectable Bone Graft market is assessed at USD 464.07 Million in 2026 and is projected to reach USD 787.05 Million by 2033, the end of the forecast period.
  • The North America Injectable Bone Graft market is anticipated to expand at a CAGR of 7.84% between 2026 and 2033.
  • In 2025, the USA held the largest share of 82.7% of the North America Injectable Bone Graft market, ahead of all other countries.
  • By Material Type, the Synthetic segment dominated with a revenue share of 52.3% in 2025, largely driven by surgeons prefer off-the-shelf synthetic pastes for spinal fusions.
  • Driven by strategic investments, capacity expansion, product innovation, and technological development, players operating in the North America Injectable Bone Graft market are witnessing additional growth opportunities.
  • As application expansion, demand, technological advancement, and geographic penetration increase, the market is expected to see steady expansion up to 2033.
  • During 2026–2033, the Dental segment is forecast to expand at the fastest CAGR of 9.8% among all Application segments.
  • Over the 2026–2033 forecast period, Canada is projected to register the fastest CAGR of 8.6%.

North America Injectable Bone Graft Market Size & Forecast

North America Injectable Bone Graft Market Size, Value & Y-o-Y Growth Chart 2019-2033

North America Injectable Bone Graft Market - Frequently Asked Questions

How do surgeons in North America choose an Injectable Bone Graft product?

Surgeons in North America choose an Injectable Bone Graft product mainly on handling and setting behaviour, clinical history and supplier service. Spinal fusion and trauma teams want pastes that stay where they are placed and set without extra steps. Hospital buying committees weigh shelf life, sterility and rep support alongside price.

Are environmental rules changing the Injectable Bone Graft market in North America?

Environmental rules are reshaping the Injectable Bone Graft market in North America, though indirectly, through sterilization methods and single-use packaging. Hospitals face pressure to cut waste from procedure kits and trays. Suppliers that reduce packaging and offer clear disposal guidance hold an edge in tenders.

How are prices for Injectable Bone Graft trending in North America?

Prices for Injectable Bone Graft in North America are under pressure from two sides, with composite products commanding premiums while commodity pastes face hospital cost controls. The high cost of advanced composite grafts remains a restraint because payers and hospitals push back on premium pricing. Volume growth in spinal fusion and trauma supports steady revenue.

What technology trends are shaping the Injectable Bone Graft market in North America?

Bio-inks and 3D bioprinting are the technology trends shaping the Injectable Bone Graft market in North America, pointing toward patient-specific graft shapes. Suppliers are also improving injectability and setting time to suit minimally invasive procedures. Preference for minimally invasive procedures is a driver behind these product changes.

What is driving demand for Injectable Bone Graft in North America?

An aging population and a high incidence of trauma are the main demand drivers for Injectable Bone Graft in North America. More elderly patients need spinal fusion and fracture repair, and minimally invasive procedures are preferred because they shorten recovery and hospital stays. Both trends widen the pool of patients suitable for injectable graft pastes.

North America Injectable Bone Graft Market Share & Segment Analysis

North America Injectable Bone Graft Market By Country 2019-2033 (USD Million)

By Country201920202021202220232024202520262027202820292030203120322033CAGR
USA214.40231.33249.60269.31290.58313.52338.28364.99393.81424.90458.45494.65533.70575.84621.307.90%
Canada36.0338.8041.7844.9948.4552.1756.1860.4965.1470.1475.5281.3287.5794.29101.537.68%
Rest of North America23.1824.9326.8128.8431.0133.3635.8838.5941.5044.6448.0151.6355.5359.7264.227.55%
Total273.61295.06318.20343.14370.04399.05430.34464.07500.45539.68581.98627.60676.79729.84787.057.84%
Source: Market Research Update, Primary InterviewsMarket Research Update

North America Injectable Bone Graft Market By Material Type 2019-2033 (USD Million)

By Material Type201920202021202220232024202520262027202820292030203120322033
Synthetic149.26160.96173.58187.18201.86217.68234.75253.15272.99294.39317.47342.36369.19398.13429.34
Allograft74.6180.4686.7793.57100.91108.82117.35126.55136.47147.17158.71171.15184.56199.03214.63
Composite49.7453.6457.8562.3867.2772.5578.2384.3790.9898.11105.80114.10123.04132.69143.09
Total273.61295.06318.20343.14370.04399.05430.34464.07500.45539.68581.98627.60676.79729.84787.05
Source: Market Research Update, Primary InterviewsMarket Research Update

North America Injectable Bone Graft Market By Application 2019-2033 (USD Million)

By Application201920202021202220232024202520262027202820292030203120322033
Spinal Fusion131.33141.63152.73164.71177.62191.55206.56222.75240.22259.05279.35301.25324.86350.33377.78
Trauma65.6770.8276.3782.3588.8195.77103.28111.38120.11129.52139.68150.62162.43175.16188.89
Dental43.7847.2150.9154.9059.2163.8568.8574.2580.0786.3593.12100.42108.29116.78125.93
Craniomaxillofacial32.8335.4138.1841.1844.4147.8951.6455.6960.0564.7669.8475.3181.2287.5894.45
Total273.61295.06318.20343.14370.04399.05430.34464.07500.45539.68581.98627.60676.79729.84787.05
Source: Market Research Update, Primary InterviewsMarket Research Update

North America Injectable Bone Graft Market By End-User 2019-2033 (USD Million)

By End-User201920202021202220232024202520262027202820292030203120322033
Hospitals149.26160.96173.58187.18201.86217.68234.75253.15272.99294.39317.47342.36369.19398.13429.34
ASCs74.6180.4686.7793.57100.91108.82117.35126.55136.47147.17158.71171.15184.56199.03214.63
Specialty Clinics49.7453.6457.8562.3867.2772.5578.2384.3790.9898.11105.80114.10123.04132.69143.09
Total273.61295.06318.20343.14370.04399.05430.34464.07500.45539.68581.98627.60676.79729.84787.05
Source: Market Research Update, Primary InterviewsMarket Research Update

Countries in North America

North America Injectable Bone Graft Market Report Scope

Report AttributesReport Details
Base Year2025
Historic Data2019-2024
Market Size in 2026USD 464.07 Million
Market Forecast in 2033USD 787.05 Million
Growth RateCAGR of 7.84%
Study Period2026-2033
Key Companies ProfiledMedtronic plc, Stryker Corporation, Johnson & Johnson (DePuy Synthes), Zimmer Biomet, Wright Medical Group N.V. (now part of Stryker), Baxter International Inc., Artoss GmbH, Xtant Medical Holdings, Inc., NuVasive, Inc. (now part of Globus Medical), Geistlich Pharma AG
Segments Covered
  • By Material Type: Synthetic, Allograft, Composite
  • By Application: Spinal Fusion, Trauma, Dental, Craniomaxillofacial
  • By End-User: Hospitals, ASCs, Specialty Clinics
Regions CoveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
Source: Market Research Update, Primary InterviewsMarket Research Update

Need it tailored? Customize your report by selecting standalone sections, regional analyses, or detailed country-level insights. Contact our experts for a tailored solution at exclusive pricing.

Customize Your Research
North America Injectable Bone Graft Market

Date: October 2026 | Base Year: 2025 | Forecast Period: 2026-2033 | Historic Period: 2019-2024

Buy Now Request Free Sample PDF

Share Chart

Single User

Our Clients